Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses

Bruno Karam, William D. Wilson, Thomas M. Chambers, Stephanie Reedy, Nicola Pusterla

Research output: Contribution to journalArticlepeer-review

Abstract

The use of a hemagglutination inhibition (HI) assay to assess humoral immune response to equine influenza virus (EIV) vaccines from various manufacturers administered to previously immunized adult horses was investigated. Subjects were allocated into one of 3 groups and vaccinated with various commercially available vaccines. Groups were subdivided into subjects that received 1 dose of a particular vaccine and those that received a second dose, 30 d later. Serum was collected at various times to assess antibody responses to contemporary EIV Florida sub-lineage strains. Statistical significance was set at P < 0.05 and all groups had a significant increase in antibody titers pre- and post-administration of the first dose. In contrast, there was no significant difference between day 30 titers and titers at subsequent time points, regardless of protocol. We concluded that administration of various commercial influenza vaccines containing a different sub-lineage clade stimulated equivalent HI antibody titers after 1 booster vaccination.

Original languageEnglish (US)
Pages (from-to)266-272
Number of pages7
JournalThe Canadian veterinary journal = La revue veterinaire canadienne
Volume62
Issue number3
StatePublished - Mar 1 2021

ASJC Scopus subject areas

  • veterinary(all)

Fingerprint Dive into the research topics of 'Hemagglutinin inhibition antibody responses to commercial equine influenza vaccines in vaccinated horses'. Together they form a unique fingerprint.

Cite this